- Home
- TNXP vs FCUV Comparison
TNXP vs FCUV Comparison
Compare TNXP & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- FCUV
- Stock Information
- Founded
- TNXP 2007
- FCUV 2012
- Country
- TNXP United States
- FCUV United States
- Employees
- TNXP N/A
- FCUV N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- FCUV Industrial Machinery/Components
- Sector
- TNXP Health Care
- FCUV Industrials
- Exchange
- TNXP Nasdaq
- FCUV Nasdaq
- Market Cap
- TNXP 19.5M
- FCUV 19.9M
- IPO Year
- TNXP N/A
- FCUV N/A
- Fundamental
- Price
- TNXP $0.61
- FCUV $0.23
- Analyst Decision
- TNXP Strong Buy
- FCUV
- Analyst Count
- TNXP 2
- FCUV 0
- Target Price
- TNXP $53.50
- FCUV N/A
- AVG Volume (30 Days)
- TNXP 202.6M
- FCUV 240.3K
- Earning Date
- TNXP 11-12-2024
- FCUV 11-07-2024
- Dividend Yield
- TNXP N/A
- FCUV N/A
- EPS Growth
- TNXP N/A
- FCUV N/A
- EPS
- TNXP N/A
- FCUV N/A
- Revenue
- TNXP $11,291,000.00
- FCUV $1,078,349.00
- Revenue This Year
- TNXP $64.71
- FCUV N/A
- Revenue Next Year
- TNXP $24.49
- FCUV N/A
- P/E Ratio
- TNXP N/A
- FCUV N/A
- Revenue Growth
- TNXP 183.05
- FCUV 247.90
- 52 Week Low
- TNXP $0.12
- FCUV $0.15
- 52 Week High
- TNXP $14.08
- FCUV $1.80
- Technical
- Relative Strength Index (RSI)
- TNXP 75.02
- FCUV 40.70
- Support Level
- TNXP $0.32
- FCUV $0.24
- Resistance Level
- TNXP $0.72
- FCUV $0.27
- Average True Range (ATR)
- TNXP 0.15
- FCUV 0.03
- MACD
- TNXP 0.04
- FCUV -0.00
- Stochastic Oscillator
- TNXP 39.61
- FCUV 10.00
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About FCUV Focus Universal Inc.
Focus Universal Inc develops and manufactures universal smart devices. Its product portfolio includes Universal Smart Instrumentation Platform, Ubiquitor, Universal Smart Controller, and Sensors. The company also supplies various air filtration systems. The Company consists of three types of operations- Focus and Focus Shenzhen (Corporate), Perfecular and Lusher (IoT Products), and AVX (IoT Installation Services). The majority of revenue is generated from IoT Installation Services. IoT Installation Services segment is an IoT installation and management company specializing in high-performance and easy-to-use audio/video, home theater, lighting control, automation, and integration.